Contra: "Anti-platelet therapy is an alternative to oral anticoagulation for atrial fibrillation"

被引：13

作者：

Apostolakis, Stavros ^{[1
]}

Shantsila, Eduard ^{[1
]}

Lip, Gregory Y. H. ^{[1
]}

Lane, Deirdre A. ^{[1
]}

机构：

[1] Univ Birmingham, Haemostasis Thrombosis & Vasc Biol Unit, Ctr Cardiovasc Sci, City Hosp, Birmingham, W Midlands, England

来源：

THROMBOSIS AND HAEMOSTASIS | 2009年 / 102卷 / 05期

关键词：

STROKE RISK; ELDERLY-PATIENTS; THROMBOPROPHYLAXIS; THROMBOEMBOLISM; CLOPIDOGREL; PREVENTION; MANAGEMENT; COUNTRIES; WARFARIN; ASPIRIN;

D O I：

10.1160/TH09-08-0563

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

[No abstract available]

引用

页码：914 / 915

页数：2

共 18 条

[1] Clopidogrel plus aspirin versus oral anticoagulation for atrial fibrillation in the Atrial fibrillation Clopidogrel Trial with Irbesartan for prevention of Vascular Events (ACTIVE W): a randomised controlled trial
Connolly, S.
Pogue, J.
Hart, R.
Pfeffer, M.
Hohnloser, S.
Chrolavicius, S.
Yusuf, S.
[J]. LANCET, 2006, 367 (9526) : 1903 - 1912
[2] Effect of Clopidogrel Added to Aspirin in Patients with Atrial Fibrillation
Connolly, S. J.
Yusuf, S.
Camm, J.
Chrolavicius, S.
Commerford, P.
Flather, M.
Hart, R. G.
Hohnloser, S. H.
Joyner, C.
Pfeffer, M.
Gaudin, C.
Blumenthal, M.
Marchese, C.
Pogue, J.
Hart, R.
Hohnloser, S.
Anand, I.
Arthur, H.
Avezum, A.
Budaj, A.
Ceremuzynski, L.
De Caterina, R.
Diaz, R.
Dorian, P.
Flaker, G.
Fox, K. A. A.
Franzosi, M. G.
Goldhaber, S.
Golitsyn, S.
Granger, C.
Halon, D.
Hermosillo, A.
Hunt, D.
Jansky, P.
Karatzas, N.
Keltai, M.
Kozan, O.
Lanas, F.
Lau, P.
Le Heuzey, J. Y.
Lewis, B. S.
Morais, J.
Morillo, C.
Paolasso, E.
Peters, R. J.
Pfisterer, M.
Piegas, L.
Pipilis, A.
Sitkei, E.
Swedberg, K.
[J]. NEW ENGLAND JOURNAL OF MEDICINE, 2009, 360 (20) : 2066 - 2078
[3] CONNOLLY SJ, 2009, N ENGL J MED
[4] Benefit of Oral Anticoagulant Over Antiplatelet Therapy in Atrial Fibrillation Depends on the Quality of International Normalized Ratio Control Achieved by Centers and Countries as Measured by Time in Therapeutic Range
Connolly, Stuart J.
Pogue, Janice
Eikelboom, John
Flaker, Gregory
Commerford, Patrick
Franzosi, Maria Grazia
Healey, Jeffrey S.
Yusuf, Salim
[J]. CIRCULATION, 2008, 118 (20) : 2029 - 2037
[5] ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation:: full text
Fuster, Valentin
Ryden, Lars E.
Cannom, David S.
Crijns, Harry J.
Curtis, Anne B.
Ellenbogen, Kenneth A.
Halperin, Jonathan L.
Le Heuzey, Jean-Yves
Kay, G. Neal
Lowe, James E.
Olsson, S. Bertil
Prystowsky, Eric N.
Tamargo, Juan Luis
Wann, Samuel
[J]. EUROPACE, 2006, 8 (09): : 651 - 745
[6] Stroke and thromboembolism in atrial fibrillation: A systematic review of stroke risk factors, risk stratification schema and cost effectiveness data
Hughes, Michael
Lip, Gregory Y. H.
[J]. THROMBOSIS AND HAEMOSTASIS, 2008, 99 (02) : 295 - 304
[7] Contra: 'Warfarin should be the drug of choice for thromboprophylaxis in elderly patients with atrial fibrillation'
Hylek, Elaine M.
[J]. THROMBOSIS AND HAEMOSTASIS, 2008, 100 (01) : 16 - 17
[8] JEFFREY S, 2009, CLIN CONDITIONS 0331
[9] LIP G, 2009, CHEST
[10] Paroxysmal atrial fibrillation, stroke risk and thromboprophylaxis
Lip, Gregory Y. H.
[J]. THROMBOSIS AND HAEMOSTASIS, 2008, 100 (01) : 11 - 13

← 1 2 →